Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
New Zealand begins two-year genomics pilot to cut cancer and rare disease test delays by processing tests locally.
New Zealand has launched a two-year pilot to bring genomic testing for cancer and rare disorders home, reducing reliance on overseas labs.
The initiative, led by Health New Zealand and supported by Illumina, will process over 6,000 samples using whole genome and comprehensive genomic profiling, aiming to shift half of currently exported tests locally.
It targets conditions like metabolic, connective tissue, eye, hearing, and kidney disorders, with cancer applications still being defined.
The program seeks to cut patient wait times, improve diagnostic accuracy, build local expertise, and save about $5 million over five years.
It also evaluates workforce readiness, operations, and data security to inform a future national genomics service.
The launch coincides with Rare Disorders Month, highlighting the importance of timely diagnosis.
Nueva Zelanda comienza un piloto de genómica de dos años para reducir los retrasos en las pruebas de cáncer y enfermedades raras mediante el procesamiento local de las pruebas.